Harvard Apparatus Regenerative Technology Inc. (HRGN)
OTCMKTS · Delayed Price · Currency is USD
1.572
0.00 (0.00%)
Apr 13, 2026, 9:30 AM EST
HRGN Market Cap
HRGN has a market cap or net worth of $27.64 million as of April 14, 2026. Its market cap has decreased by -16.58% in one year.
Market Cap
27.64M
Enterprise Value
26.48M
Revenue
704.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.57
Market Cap Chart
Since October 21, 2013, HRGN's market cap has decreased from 48.00M to 27.64M, a decrease of -42.42%. That is a compound annual growth rate of -4.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 27.64M | -12.52% |
| Dec 31, 2025 | 31.59M | -33.41% |
| Dec 30, 2024 | 47.44M | -31.84% |
| Dec 29, 2023 | 69.60M | 3.94% |
| Dec 30, 2022 | 66.96M | 170.54% |
| Dec 31, 2021 | 24.75M | 110.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cell Source | 56.84M |
| Vicapsys Life Sciences | 47.26M |
| Arch Biopartners | 27.09M |
| Provectus Biopharmaceuticals | 23.96M |
| Anebulo Pharmaceuticals | 21.93M |
| Zenith Capital | 21.56M |
| Zeo ScientifiX | 15.36M |
| Oncotelic Therapeutics | 15.34M |